BrainScope

Recent NFL news on concussions and Parkinson’s disease has brought renewed focus on the long-term consequences of repeated head impacts in football. BrainScope’s published research demonstrated that repetitive head trauma is reflected in changes in brain electrical activity often linked to neurodegenerative diseases. This insight is crucial for advancing brain health diagnostics and athlete safety. Read more here: https://bwnews.pr/4eoYaml #NeuroHealth #ConcussionAwareness #BrainScope #ParkinsonsResearch

BrainScope is having an incredible time at #ACEP2024! We're grateful for the interest and connections from Emergency Physicians worldwide in our technology. Please stop by Booth 1826 between today and tomorrow to learn how BrainScope can support reducing length of stay, diverting unnecessary head CTs, and providing an objective concussion assessment! Laurie Silver Chris Randby Jeff Barish Joe Stauffer

Are you attending #ACEP24? BrainScope will be there! Stop by booth 1826 to learn about how our breakthrough technology can improve the current care pathway for mild head injured patients.

We are excited to announce that BrainScope has been named MedTech Outlook’s Brain Diagnostics Device Company of the Year for 2024! 🎉 This award recognizes our groundbreaking work in neurodiagnostics, including our development of machine learning and EEG-based biomarkers for point-of-care assessments. We’re also thrilled to be featured in a two-page article, showcasing how our FDA-cleared biomarkers are revolutionizing brain health diagnostics, from brain injuries to Alzheimer’s and stroke. BrainScope is at the forefront of revolutionizing brain health, aiming to improve patient care worldwide. Read more here: https://bit.ly/4dMZ6QT #Innovation #BrainHealth #MedTechOutlook #BrainScope #Alzheimers #Parkinsons

There is an urgent need for quantitative markers that reflect brain dysfunction for improved brain health assessment and monitoring of drug side effects. This presents quite an opportunity for BrainScope‘s deep expertise using brain electrical activity (EEG) paired with advanced AI for development of objective neuro-biomarkers. EEG-based biomarkers have many benefits over traditional markers used in healthcare and pharma today – they are non-invasive, rapid, inexpensive, accessible, and can pick up abnormalities even when no physical symptoms are present. We’re honored to have been invited to attend Longwood Healthcare Leader’s Spring MIT, a networking and brainstorming forum focused on further cultivating biomedical innovation and the advancement of medicines. Having validated outcomes of our three FDA-cleared, EEG-based biomarkers for brain bleed and concussion, we’re excited about the opportunity to meet with pharmaceutical and biotech industry leaders and discuss how we can leverage our deep learning neurotechnology platform across other CNS indications such as Alzheimer’s and Parkinson’s. #BrainScope #brainhealth #Alzheimer’s #Parkinson’s #ARIA

BrainScope has been busy this week talking to brain trauma and concussion thought leaders from around the world. We are grateful for the opportunity to make a real difference in the field.

BrainScope was honored to present at the @USAMRDC / @BARDA Neurotrauma State of Technology conference last week. We have demonstrated the utility of our 3 AI-based biomarkers for brain bleed and concussion in the toughest market (hospital EDs) with outstanding results. Other than CTs there are no objective markers for head injury in use, and CTs can’t pick up concussion (only brain bleeds). It’s time to make BrainScope’s much needed TBI assessment technology available to our service members, veterans, athletes and families. #tbi #traumaticbraininjury #braininjury #headinjury #braintrauma #concussion #usamrdc #barda #mtec #dod #wbh #medicalinnovations

BrainScope is the first and only FDA-cleared non-invasive medical device that objectively assesses mild head-injured patients for brain bleeds and concussions. Read more about our technology here: #BrainScope #concussion #BrainHealth #hedainjury https://bit.ly/3P1iVtt

We are excited to announce our latest article, Identification of Concussion Subtypes based on Intrinsic Brain Activity, was published in JAMA Network Open on February 13th! The cohort study of 771 participants with clinically diagnosed concussion were evaluated with BrainScope at the time of injury. Using this data, BrainScope was able to create new AI/ML-based biomarkers identifying distinct subtypes of concussion. This breakthrough highlights the existence of diverse underlying pathophysiologies and opens doors for personalized treatment, prognosis, and improved care. Read the article here: https://bit.ly/49wopEz